Wayland Group (WAYL.C) selling once hyped foreign assets for pennies on the dollar

As part of an ongoing process to deal with its bankruptcy, Wayland Group (WAYL.C) is dispensing with several foreign assets that were once touted as being amazing international opportunities, and it's doing so at prices you can afford. The courts have granted approval for WAYL to get rid of its Colombian subsidiary, Colmed Pharmaceuticals, which was purchased in an all paper deal for 11 million shares a little over a year ago. Who's buying it? It turns out, one of the companies that originally sold it to them, RG5 Investments.